ijps 2021
DOI: 10.36468/pharmaceutical-sciences.spl.262
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Study of Rituximab Combined with Chemotherapy in the Treatment of Lymphoma with Hypergammaglobulinemia

Abstract: Wu et al.: Clinical Efficacy of Rituximab Combined with Chemotherapy in Hypergammaglobulinemia PatientsTo further evaluate the clinical influencing factors of rituximab in the treatment of diffuse large B cell lymphoma patients with hypergammaglobulinemia by studying the clinical efficacy of rituximab combined with chemotherapy in patients with hypergammaglobulinemia. 89 patients with diffuse large B cell lymphoma treated in our hospital from January 2011 to December 2020 were selected as subjects. After infor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 8 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?